Trader Note — 2439 total
Smooth Rock Ventures Corp. heads into its May 4 earnings release with a price that has gone nowhere this week, a short position that has all but vanished, and insider buying that is modest but consistent. The most…
AYI enters the final stretch of April with a notable divergence: short sellers are pulling back while options traders have turned more bullish — a setup that runs against the cautious tone that dominated just two weeks…
Enerpac Tool Group has had a decent week on price — up 2.1% to $36.08 — but the improvement arrives in the shadow of a sharp earnings-driven selloff in late March, and the Street's valuation expectations sit well above…
MRC enters the final days of April with one story dominating the tape — a persistent insider accumulation campaign that has run for six weeks and shows no sign of stopping. Sime Armoyan, a declared 10% shareholder, has…
CDN Maverick Capital Corp. enters the week trading at C$0.21, a 5% gain over the past five days, with an earnings event flagged for May 6 — the clearest near-term focal point for this micro-cap diversified metals…
Acme United Corporation enters the final trading day of April nursing its worst weekly loss in recent memory — down 9.4% on the week to $41.66, with a further 0.8% decline on Tuesday. The most striking part of the…
ACD enters the final days of April carrying the weight of a deeply difficult 2025. Revenue fell from CAD 83 million to CAD 62 million last year, and the net loss widened to CAD 30 million — compared with just CAD 3…
Abeona Therapeutics heads into its May 13 earnings call with one of the most extreme short setups in the biotech universe — and a 25% monthly price rally making that position increasingly uncomfortable. Short sellers…
Acadia Realty Trust heads into Q1 earnings season with short sellers trimming positions sharply over the past month — yet the stock remains one of the most contested names in the retail REIT space. The headline shift…
ASCN shares have moved sharply higher this week — up 7.2% to $118.99 — with no accompanying news, no analyst coverage, and almost no short-side activity to speak of. The price action is the story. ASCN closed Tuesday…
AAB heads into its May 4 earnings release with the lending market for its shares quietly tightening — a notable shift for a micro-cap that rarely attracts much short-side attention. The most striking move this week is…
Oregen Energy Corp. has slipped 5% over the past month to CAD 0.10, and the most telling signal on the small Canadian explorer right now is not in the lending market — it is in what insiders have been doing with their…
Abercrombie & Fitch is heading into its May 27 earnings report with an uncomfortable combination: a stock down 10.5% on the week, a Street that has been steadily trimming targets, and — unusually — options positioning…
ABI, the Quebec-focused gold and silver junior, enters the final days of April with a fresh drill hit, a new director, and a short position that has been rapidly rebuilt and then partially unwound — all while the stock…
ABT heads into the back half of April with insiders putting money to work at a stock that has fallen nearly 26% year-to-date — even as a wave of analyst target cuts follows the company's Q1 earnings miss. The most…
Abacus Mining & Exploration heads into its May 4 results with a notable pattern: every time the stock has dipped, CEO Paul Anderson has bought more. The insider angle is the clearest signal here. Anderson has made four…
Vericel Corporation arrives at its May 7 Q1 earnings with a recovering share price, a meaningful short position that has been quietly unwinding, and analyst targets that still sit well above where the stock trades. The…
AZZ Inc. posted a sharp 7.4% earnings-day jump last week, and analysts have promptly repriced the stock higher — but insiders used the rally to take money off the table. The week's defining dynamic is the gap between a…
AXTI reports Q1 2026 results tomorrow evening carrying one of the most aggressive analyst re-ratings in its recent history — and a short base that has been quietly rebuilt into the event. Wedbush's Matt Bryson moved…
Sarepta Therapeutics reports Q1 2026 results on May 6, and the setup heading in is tense: short interest is running near its highest level in months, a fresh spike in options defensiveness just appeared, and the most…
